Acrux Limited (ASX:ACR) Launches Dapsone 7.5% Gel in the United States
Acrux Limited (ASX:ACR) launches its differentiated Dapsone 7.5% Gel in the US, enhancing its prescription acne treatment portfolio.
Category: ASX-ACR
Acrux Limited
Latest News
Jameson Resources (ASX:JAL) Announces Feasibility Update and Reserve Confirmation for Crown Mountain Project
Yowie Group Limited (ASX:YOW) Announces Scrip Takeover Bid for Keybridge Capital Limited
Donaco International Limited (ASX:DNA) Updates Scheme Timetable and Cambodian Tax Position
Black Dragon Gold Corp (ASX:BDG) Reports Q1 2025 Financial Results and Project Updates
Augustus Minerals (ASX:AUG) Acquires ACMPNG and Advances Mt Kare Gold Project License
Arika Resources Limited (ASX:ARI) Upsizes Drilling Program
VHM Limited (ASX:VHM) Announces Equity Raising and Project Update
NZME Limited (ASX:NZM) Updates Director Nominations
Wide Open Agriculture (ASX:WOA) Secures $2.6M Placement & Launches SPP
REA Group Ltd (ASX:REA) Delivers Strong Q3 Results
The Hub of Australian Finance News